TERRY JO BROOKS-DEVLIN: Open Payments
NPI 1831526763 · TONAWANDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$53,230 in 270 payments from 17 companies in 2025. Trend: 2023 $38,911 · 2024 $34,279 · 2025 $53,230
Speaker / faculty: $27,585Consulting: $11,930Food & beverage: $5,444Honoraria: $5,375Travel & lodging: $2,829Education: $66
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 54 | $18,089 |
| Alkermes, Inc. | 47 | $16,120 |
| Teva Pharmaceuticals USA, Inc. | 48 | $10,095 |
| Axsome Therapeutics, Inc. | 19 | $6,976 |
| Neurocrine BioSciences, Inc. | 26 | $541 |
| Otsuka America Pharmaceutical, Inc. | 25 | $443 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $306 |
| Vanda Pharmaceuticals Inc. | 14 | $255 |
| Lundbeck LLC | 9 | $169 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
Products named: LYBALVI, COBENFY, UZEDY, Auvelity, ARISTADA, INGREZZA, REXULTI, CAPLYTA.
Industry payments across NY — which companies pay providers there.
